{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-037114","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2026-09-18T20:06:23+00:00","discovered_at":"2026-09-18T20:07:01.069774+00:00","generated_at":"2026-09-18T20:07:08.969277+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Grace Therapeutics annual meeting: directors re-elected, say-on-pay approved","bullets":["Annual meeting held Sept 17, 2026; 9,973,325 shares present (61.28% of 16,274,026 outstanding).","All five director nominees elected: Kavuru, Davis, Kohli, Kottayil, Neugeboren, each with ~6.0M votes for.","Say-on-pay approved: 5,740,999 for vs 222,775 against (93% support excluding broker non-votes).","KPMG LLP ratified as auditor for FY2027: 9,878,292 for, 63,381 against.","Shareholders favor 1-year frequency for say-on-pay (5,772,652 votes); board adopts annual vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-037114","json":"https://secwatch.observer/filing/0001140361-26-037114.json","markdown":"https://secwatch.observer/filing/0001140361-26-037114.md","text":"https://secwatch.observer/filing/0001140361-26-037114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/0001140361-26-037114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/ef20082416_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-18T20:07:08.969277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}